Arbutus Biopharma Corporation ABUS Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's shares (basic)?
- Arbutus Biopharma Corporation (ABUS) reported shares (basic) of 193.8M in Q1 2026.
- How has Arbutus Biopharma Corporation's shares (basic) changed year-over-year?
- Arbutus Biopharma Corporation's shares (basic) increased by 1.6% year-over-year, from 190.7M to 193.8M.
- What is the long-term trend for Arbutus Biopharma Corporation's shares (basic)?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's shares (basic) has grown at a 17.8% compound annual growth rate (CAGR), from 397.8M to 765.6M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.